Application 075446
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BETAXOLOL HYDROCHLORIDE | BETAXOLOL HYDROCHLORIDE | SOLUTION/DROPS;OPHTHALMIC | EQ 0.5% BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075446-001 | BETAXOLOL HYDROCHLORIDE | BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | SOLUTION/DROPS / OPHTHALMIC | 2000-09-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A075446-001 | BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | SOLUTION/DROPS / OPHTHALMIC | 2000-09-28 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A075446-001 | BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | SOLUTION/DROPS / OPHTHALMIC | 2000-09-28 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075446-001 | BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | SOLUTION/DROPS / OPHTHALMIC | 2000-09-28 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075446-001 | BETAXOLOL HYDROCHLORIDE | EQ 0.5% BASE | SOLUTION/DROPS / OPHTHALMIC | 2000-09-28 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betoptic S | BETAXOLOL HYDROCHLORIDE | Novartis Pharmaceuticals Corporation | 905ba189-456c-4aa4-8231-39a971374ad8 | 2025-01-22 | Warnings, Adverse reactions | BETAXOLOL HYDROCHLORIDE |
| BETAXOLOL HYDROCHLORIDE | BETAXOLOL HYDROCHLORIDE | KVK-TECH, INC. | f3b50bbb-df03-4ed7-9d8d-180edc2abd54 | 2024-04-30 | Warnings, Adverse reactions | BETAXOLOL HYDROCHLORIDE BETAXOLOL HYDROCHLORIDE |
| Betaxolol Hydrochloride | BETAXOLOL HYDROCHLORIDE | Sandoz Inc | a73519d5-546c-4377-92ed-0d4be2685d60 | 2023-10-31 | Warnings, Adverse reactions | Betaxolol Hydrochloride BETAXOLOL HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 30886 | ORIG | 2000-09-28 |